Tortugas Neuroscience completes $106 million seed and Series A financing, with Cure Ventures leading
Framingham-based Tortugas Neuroscience announced a $106 million seed and Series A financing led by Cure Ventures, with The Column Group and AN Venture Partners participating. Source alignment confirms the funding amount, lead investor, and participating firms; however, details on the use of proceeds, the scope of the candidate drugs, and the company’s background are not fully consistent across sources, and some information cannot be verified from the provided materials.